−£32.50m
vs Dec 2023Active03783386Private limited companyGuildford
MEDPHARM LIMITED
Significant control: Medpharm Holdco Limited (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Medpharm Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Medpharm Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
MEDPHARM LIMITED is an active private limited company (company number 03783386) incorporated on 7 June 1999, registered in Guildford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest full accounts cover the period ending 31 December 2024, showing net assets of −£32.50m and cash of £217k, with 78 employees on average. Turnover was £9.04m and profit for the year −£26.20m. Net assets fell 416% on the prior period (−£6.29m).
Peer position · net assets
By net assets it sits in the bottom quarter of 54 comparable companies in Surrey (median £1,000, upper quartile £121k).
02
Ownership and control
- Medpharm Holdco Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Dr Andrew Gordon Muddle
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 7 June 199927 yrs ago
- Next accounts due
- 30 September 202625 days overdue
- Confirmation statement due
- 21 June 2027in 239 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Full
- Size band
- SmallCompanies Act thresholds
05
Financials
£217k
−62%vs Dec 2023£9.04m
−20%vs Dec 202378
−17%vs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | −£32.50m | £217k | — | £41.46m | £9.04m | −£26.20m | 78 |
| 31 December 2023 | −£6.29m | £575k | — | £13.91m | £11.30m | −£6.87m | 94 |
| 1 January 2023 | — | — | — | — | — | — | — |
Current ratio0.16Current assets ÷ creditors within one year
Net margin-289.8%Profit for the year ÷ turnover
Cash per employee£2,778Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-32,500,104 at 31 December 2024
- Net assets down 25% or more on the prior period-416.5% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.16
- Cash at bank of £50,000 or moreCash £216,669
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 7 June 1999
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 239 days
- Next accounts due25 days overdue
- Accounts period endNet liabilities £32.50m · full accounts
- Accounts period endNet liabilities £6.29m · full accounts
- Accounts period end
- Incorporated
08
Similar companies in Surrey
- FUTURA MEDICAL DEVELOPMENTS LIMITEDGuildford · inc. Oct 1997
- IVY MEDICAL CHEMICALS DEVELOPMENT LIMITEDGodalming · inc. Sept 1997
- THE BRYANSTON TECHNOLOGY GROUP LTDGodalming · inc. Oct 2001
- M R RESEARCH SYSTEMS LTDGuildford · inc. Oct 2002
- HAEMOSTATIX LIMITEDGuildford · inc. Mar 2003
- MEDSA RESEARCH LTDFarnham · inc. May 2003
All companies incorporated on 7 June 1999 · in Jun 1999.
09
Reminders for MEDPHARM LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.